Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease

Andrew J Wilson; Daniel S Martin; Victoria Maddox; Simon Rattenbury; Davis Bland; Sanjay Bhagani; Ian Cropley; Susan Hopkins; Stephen Mepham; Alison Rodger; Simon Warren; Pratima Chowdary; Michael Jacobs

doi:10.1093/cid/civ977

Thromboelastography in the Management of Coagulopathy Associated With Ebola Virus Disease

Clin Infect Dis. 2016 Mar 1;62(5):610-612. doi: 10.1093/cid/civ977. Epub 2015 Nov 26.

Authors

Affiliations

¹ Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHSFoundation Trust.
² Division of Surgery, University College London.
³ Department of Infection, Royal Free London NHS Foundation Trust, United Kingdom.
⁴ Haemonetics Corporation, Braintree, Massachusetts.
⁵ Research Department of Infection and Population Health, University College London, United Kingdom.

PMID: 26611775
DOI: 10.1093/cid/civ977

Abstract

Here, we describe the first use of thromboelastography (TEG) in the management of 2 cases of Ebola virus disease. Early in their illness, both patients had evidence of a consumptive coagulopathy. As this resolved, TEG demonstrated that both developed a marked hypercoagulable state, which was treated with low-molecular-weight heparin.

Keywords: Ebola; clotting; coagulopathy; thromboelastography.

Publication types

Case Reports
Evaluation Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Blood Coagulation Disorders / diagnosis*
Blood Coagulation Disorders / etiology
Female
Hemorrhagic Fever, Ebola / complications*
Humans
Thrombelastography*